Here’s why Jim Cramer is warning investors to stay away from ScottsMiracle-Gro

Here’s why Jim Cramer is warning investors to stay away from ScottsMiracle-Gro


CNBC’s Jim Cramer on Thursday told investors to resist the urge to add ScottsMiracle-Gro to their portfolios, despite the stock’s low valuation.

“Historically, this is a great time of year for anything garden related because it’s planting season, and Scotts is a name that we used to get a ton of questions about. … But, over the past thirteen months, these shares have been obliterated,” the “Mad Money” host said.

“While ScottsMiracle-Gro might seem cheap on a price to earnings basis, the problem is that the earnings forecast keeps coming down … and management doesn’t have a handle on how bad it’s going to get,” he later added.

ScottsMiracle-Gro stock fell 6% on Thursday. The company reported better-than-expected earnings in its previous quarter two days before.

JPMorgan upgraded ScottsMiracle-Gro to overweight from neutral on Wednesday, pointing to the stock’s valuation, high margins and market leadership. Stifel downgraded the stock from overweight to hold.

Cramer said that he agrees with Stifel’s more bearish stance on Scotts, particularly because of the company’s struggles with rising raw costs, lack of confidence regarding an earnings target of $8 a share and his concerns with the performance of Scotts’ Hawthorne division. Hawthorne operates in cannabis, an industry Cramer says has been beaten down for the last year.

“On top of that, Scotts has an ugly enough balance sheet that they don’t see management embracing an aggressive buyback, either. In short, business is bad and there’s not much Scotts can do to make it better,” Cramer said.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More